Clinical Trials | April 15, 2024
Teva confirms efficacy and safety of Ajovy for prevention of migraine
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
The company plans to add 1700 beds by FY27 through the organic route
New leadership team announced at NATHEALTH Annual General Meeting 2024
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
The board gave in-principle approval for expansion of company's footprint in Lucknow
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
Subscribe To Our Newsletter & Stay Updated
